Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3,121 Cr₹2,413 Cr₹2,152 Cr₹1,813 Cr₹920 Cr

What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Operating Activities ratio of MANKIND PHARMA is ₹3,121 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹3,121 Cr
Mar2025₹2,413 Cr
Mar2024₹2,152 Cr
Mar2023₹1,813 Cr
Mar2022₹920 Cr

How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹3,121 Cr
29.33
Mar2025 ₹2,413 Cr
12.12
Mar2024 ₹2,152 Cr
18.70
Mar2023 ₹1,813 Cr
97.15
Mar2022 ₹920 Cr -

Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,839.7 Cr -4.5% 2.7% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.5%

2.7%

-2.1%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses